Manganese transport through human erythrocyte membranes. An EPR study.
Manganese uptake by human erythrocytes was investigated in the concentration range 0.5-20 mM in the suspending solution, by using the EPR technique. S shaped dependencies of manganese influx on manganese doping solution concentration for both fresh and vanadate treated erythrocytes were found, with maximum influx values of 4.1 +/- 1.9 x 10(-10) mol/m2 x s and 2.1 +/- 0.3 x 10(-9) mol/m2 x s, respectively. At low manganese concentrations (< 2 mM) the manganese permeability coefficient increases with increasing the doping concentration, the ions cooperate for achieving a transport event. For high manganese concentration (> 5 mM) the permeability coefficient decreases with increasing the doping concentration, the ions competing for the limited amount of transport system. A similar increase in manganese uptake as in vanadate treated erythrocytes was measured for 'in vitro' aged erythrocytes. These results might suggest that human erythrocytes possess an active transport mechanism by which, they oppose to manganese influx. This hypothesis is also supported by the 10-15 min time lag between the moment of doping and the start of the manganese influx into the fresh erythrocytes. The manganese uptake inhibition by nifedipine, a calcium channel blocker, for the case of vanadate treated erythrocytes, suggests that, at least partially, manganese uptake by the cells occurs via the 'calcium channels'.
Lucaciu
C M
CM
University of Medicine and Pharmacy, Faculty of Pharmacy, Department of Biophysics and Radiopharmacy, Cluj-Napoca, Romania.
Dragu
C
C
Copăescu
L
L
Morariu
V V
VV
D001693:Biological Transport, Active / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000494:pharmacology; D015220:Calcium Channels / Q000378:metabolism; D002463:Cell Membrane Permeability; D004058:Diffusion; D004578:Electron Spin Resonance Spectroscopy / Q000379:methods; D004910:Erythrocyte Membrane / Q000378:metabolism*; D004912:Erythrocytes / Q000187:drug effects; D006801:Humans; D008345:Manganese / Q000378:metabolism*; D008956:Models, Chemical; D009543:Nifedipine / Q000494:pharmacology; D014638:Vanadates / Q000494:pharmacology
D002121:Calcium Channel Blockers; D015220:Calcium Channels; D014638:Vanadates; D008345:Manganese; D009543:Nifedipine